Anti-Tumor Proliferation Activity of hIL-29 Variant
CSTR:
Author:
Affiliation:

Clc Number:

Q71

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    In order to analyze the antineoplastic activity of human interleukin-29(hIL-29) variant,a mutant gene of hIL-29 was amplified by megaprimer PCR,and the Arg35 of hIL-29 peptide chain was mutated to Lys35. A recombinant plasmid was constructed and transformed into Pichia pastoris GS115,the recombinant protein rhIL-29mut35 was induced and purified. The purified rhIL-29mut35 had a relative molecular mass of about 23×103 on SDS-PAGE profile and showed specific reaction with goat anti-human IL-29 polyclonal antibody in Western blotting. With the Cell Counting Kit-8 reagent,the rhIL-29mut35 was found to has anti-proliferation effect on tumor cells SGC7901,BEL7402,A549 and HCT8 separately with inhibition ratios of (34.20±1.50)%,(27.30±0.31)%,(30.20±0.68)% and(29.13±1.40)% in the high dose group. The anti-proliferation effect of rhIL-29mut35 was stronger than that of wild type rhIL-29(P<0.01),which supported the development of antineoplastic drugs of IL-29.

    Reference
    Related
    Cited by
Get Citation

LI Liyun, LU Yuan, GE Chunlei, PENG Ronggang, LI Xinzhe, TAN Jing, CHEN Yongkang, CHEN Wei. Anti-Tumor Proliferation Activity of hIL-29 Variant[J]. Journal of Food Science and Biotechnology,2017,36(5):553-559.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:
  • Revised:
  • Adopted:
  • Online: July 05,2017
  • Published:
Article QR Code

Copy Right:Editorial Board of Journal of Food Science and Biotechnology

Address:No. 1800, Lihu Avenue, Wuxi 214122, Jiangsu Province,China  PostCode:214122

Phone:0510-85913526  E-mail:xbbjb@jiangnan.edu.cn

Supported by:Beijing E-Tiller Technology Development Co., Ltd.

WeChat

Mobile website